港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

同源康醫藥-B

27.500

+0.000

成交量：198.15萬

成交額：5,344.88萬

市值：102.03億

市盈率：-22.54

高：28.000

開：28.000

低：26.300

收：27.500

資料載入中...

總覽公司新聞資訊公告

同源康醫藥-B04月25日主力淨流入296萬元散户資金拋售

同源康醫藥(02410.HK)投資1,800萬人民幣參與設立基金

阿斯达克财经

同源康醫藥-B訂立合夥協議

同源康醫藥-B(02410)擬出資1800萬元參設基金重點投資生物製藥業務

甲磺酸艾多替尼片(TY-9591)提交Pre-NDA申請

中證港股通化學藥綜合指數報2128.93點，前十大權重包含同源康醫藥-B等

同源康醫藥-B04月16日獲主力加倉2008萬元

港股異動 | 同源康醫藥-B(02410)尾盤漲超6% TY-9591入選ASCO本土創新藥企實現技術突破

智通财经网

同源康醫藥-B04月14日主力淨流出79萬元散戶資金買入

每日賣空追蹤 | 同源康醫藥-B 04月11日賣空量成交5000股，賣空比例為0.22%

同源康醫藥-B04月10日主力淨流入318萬元散戶資金拋售

同源康醫藥(02410)TY-9591入選ASCO 本土創新藥企實現技術突破

同源康醫藥-B盤中異動股價大跌5.66%報25.000港元

每日賣空追蹤 | 同源康醫藥-B 04月07日賣空量成交1500股，賣空比例為0.09%

同源康醫藥-B盤中異動股價大跌5.99%

同源康醫藥-B盤中異動股價大跌5.27%

每日賣空追蹤 | 同源康醫藥-B 04月02日賣空量成交1.15萬股，賣空比例為0.22%

同源康醫藥公佈2024年業績，關鍵產品商業化潛力進一步釋放

一週港股牛熊榜 | 醫藥股霸榜！同源康醫藥-B升逾25%，三生製藥升近20%；越疆陷虧損泥沼，跌近15%

同源康醫藥-B03月28日獲主力加倉5365萬元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02410/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康醫藥-B","latestPrice":27.5,"timestamp":1745568503030,"preClose":27.5,"halted":0,"volume":1981500,"delay":0,"floatShares":366000000,"shares":371000000,"eps":-1.220191602832092,"marketStatus":"休市中","change":0,"latestTime":"04-25 16:08:23","open":28,"high":28,"low":26.3,"amount":53448825,"amplitude":0.061818,"askPrice":27.5,"askSize":4000,"bidPrice":26.55,"bidSize":3500,"shortable":3,"etf":0,"ttmEps":-1.220191602832092,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745803800000},"marketStatusCode":7,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":27.5,"openAndCloseTimeList":[[1745544600000,1745553600000],[1745557200000,1745568000000]],"volumeRatio":0.8861410491559961,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":366000000,"roa":"-28.86%","roe":"--","lyrEps":-1.220192,"volumeRatio":0.8861410491559961,"shares":371000000,"dividePrice":0,"high":28,"amplitude":0.061818,"preClose":27.5,"low":26.3,"week52Low":12.86,"pbRate":"20.43","psRate":"89563.71","week52High":56.55,"institutionHeld":0,"latestPrice":27.5,"committee":-0.066667,"eps":-1.220191602832092,"divideRate":0,"volume":1981500,"delay":0,"ttmEps":-1.220191602832092,"open":28,"prevYearClose":47.15,"prevWeekClose":27.3,"prevMonthClose":34.2,"prevQuarterClose":34.2,"fiveDayClose":27.45,"twentyDayClose":31.3,"sixtyDayClose":23.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530890935","title":"同源康醫藥-B04月25日主力淨流入296萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2530890935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530890935?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 16:16","pubTimestamp":1745568989,"startTime":"0","endTime":"0","summary":"04月25日，同源康医药-B股价收平报27.50元，成交金额5344万元，换手率0.54%，振幅6.18%，量比0.88。同源康医药-B今日主力资金净流入296万元，上一交易日主力净流出301万元。该股近5个交易日下跌3.64%，主力资金累计净流出193万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入2.01亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170606a466931a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170606a466931a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1515","BK1161","02410"],"gpt_icon":0},{"id":"2530952970","title":"同源康醫藥(02410.HK)投資1,800萬人民幣參與設立基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2530952970","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530952970?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 00:14","pubTimestamp":1745511240,"startTime":"0","endTime":"0","summary":"同源康医药－Ｂ(02410.HK) 公布关连交易，与腾远长兴、湖州创新、湖州产业投资、长兴兴长投资及上海友南设立基金，主要专注于生物医药行业的早期发展项目，初始资金投入2亿人民币。其中，公司作为有限合伙人投资1,800万人民币，持股9%。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240819111845079_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240819111845079_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1435802/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1574","159938","BK1161","09939","02410"],"gpt_icon":0},{"id":"2529931234","title":"同源康醫藥-B訂立合夥協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2529931234","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529931234?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 21:49","pubTimestamp":1745502540,"startTime":"0","endTime":"0","summary":"格隆汇4月24日丨同源康医药-B公告，于2025年4月24日，公司与腾远长兴、湖州创新、湖州产业投资、长兴兴长投资及上海友南订立合伙协议，据此，订约方同意设立基金，公司将作为有限合伙人参与新成立的基金。公司认为腾远长兴将为基金带来裨益，并经考虑这一点及合伙人的经验及人脉网络后，公司认为集团参与基金可有效利用其现有财务资源及改善潜在资本收益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424215412a465749f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424215412a465749f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","09939","BK1515","BK1574"],"gpt_icon":0},{"id":"2529986521","title":"同源康醫藥-B(02410)擬出資1800萬元參設基金重點投資生物製藥業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2529986521","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529986521?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 19:58","pubTimestamp":1745495932,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 公布，于2025年4月24日，该公司与腾远长兴、湖州创新、湖州产业投资、长兴兴长投资及上海友南订立合伙协议，据此，订约方同意设立基金，公司将作为有限合伙人参与新成立的基金。根据合伙协议，公司同意向基金投资人民币1800万元。公告称，集团为即将进入商业化阶段的生物制药公司。集团作出的注资将不会对集团的财务状况及经营业绩造成任何不利影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","159938","09939","02410","BK1161"],"gpt_icon":0},{"id":"2529616793","title":"甲磺酸艾多替尼片(TY-9591)提交Pre-NDA申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2529616793","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529616793?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 10:34","pubTimestamp":1745462059,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药今日宣布，已于近日向国家药品监督管理局药品审评中心提交了其在研1类新药甲磺酸艾多替尼片的Pre-NDA申请，该药有望成为全球首款针对非小细胞肺癌脑转移患者的第三代EGFR -TKI。同时，甲磺酸艾多替尼片显示出良好的安全耐受性，未发现新的安全性风险。目前全球尚无针对NSCLC脑转移适应症的第三代EGFR-TKIs获批上市，甲磺酸艾多替尼有望满足该类患者人群亟待解决的的临床治疗需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","TY","02410"],"gpt_icon":0},{"id":"2529873901","title":"中證港股通化學藥綜合指數報2128.93點，前十大權重包含同源康醫藥-B等","url":"https://stock-news.laohu8.com/highlight/detail?id=2529873901","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529873901?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 17:42","pubTimestamp":1745228520,"startTime":"0","endTime":"0","summary":"金融界4月21日消息，上证指数低开高走，中证港股通化学药综合指数 报2128.93点。数据统计显示，中证港股通化学药综合指数近一个月下跌1.69%，近三个月上涨13.48%，年至今上涨6.46%。从中证港股通化学药综合指数持仓样本的行业来看，药品制剂占比92.37%、原料药占比7.63%。遇临时调整时，当中证港股通综合指数调整样本时，样本随之进行相应调整。若中证港股通综合指数样本有特殊事件发生，导致其行业归属发生变化，指数样本进行相应调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421174351a460cbc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421174351a460cbc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1161","09939","02410","HSTECH"],"gpt_icon":1},{"id":"2527264712","title":"同源康醫藥-B04月16日獲主力加倉2008萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527264712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527264712?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 16:16","pubTimestamp":1744791411,"startTime":"0","endTime":"0","summary":"04月16日, 同源康医药-B股价涨4.97%，报收27.45元，成交金额7017万元，换手率0.73%，振幅10.71%，量比1.94。同源康医药-B今日主力资金净流入2008万元，上一交易日主力净流入101万元。该股近5个交易日上涨4.61%，主力资金累计净流入3538万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2.37亿元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416174030a45aec28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416174030a45aec28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02410","BK1515","09939"],"gpt_icon":0},{"id":"2527325671","title":"港股異動 | 同源康醫藥-B(02410)尾盤漲超6% TY-9591入選ASCO本土創新藥企實現技術突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2527325671","media":"智通财经网","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527325671?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 15:20","pubTimestamp":1744788000,"startTime":"0","endTime":"0","summary":"同源康医药-B尾盘涨超6%，截至发稿，涨5.54%，报57.6港元，成交额4703.9万港元。消息面上，2025年美国临床肿瘤学会年会将于2025年5月30日至6月3日于美国芝加哥举行。同源康医药核心产品TY-9591的最新研究成果也入选2025年美国临床肿瘤学会大会报告。这是TY-9591首次亮相ASCO大会，并荣获口头报告。由于出色的关键II期临床试验结果，TY-9591有望成为全球第一个获批脑转移适应症的三代EGFR抑制剂。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-16/doc-inetiwey0209077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1161","02410","TY","BK1515","09939","159938","06978","159992"],"gpt_icon":0},{"id":"2527476137","title":"同源康醫藥-B04月14日主力淨流出79萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2527476137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527476137?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 16:17","pubTimestamp":1744618644,"startTime":"0","endTime":"0","summary":"04月14日, 同源康医药-B股价跌2.04%，报收26.45元，成交金额3225万元，换手率0.33%，振幅4.63%，量比0.74。同源康医药-B今日主力资金净流出79万元，上一交易日主力净流入1187万元。该股近5个交易日上涨0.19%，主力资金累计净流入1310万元；近20日主力资金累计净流入2.14亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414171644a6b9dcb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414171644a6b9dcb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02410","09939","BK1515","BK1161"],"gpt_icon":0},{"id":"2526766625","title":"每日賣空追蹤 | 同源康醫藥-B 04月11日賣空量成交5000股，賣空比例為0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526766625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526766625?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 20:12","pubTimestamp":1744373556,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间04月11日，涨1.69%，卖空量成交5000股，较上一交易日增加100%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411201245a4562ad9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411201245a4562ad9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","02410","BK1574","BK1161"],"gpt_icon":0},{"id":"2526306235","title":"同源康醫藥-B04月10日主力淨流入318萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2526306235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526306235?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 16:17","pubTimestamp":1744273025,"startTime":"0","endTime":"0","summary":"04月10日, 同源康医药-B股价涨1.92%，报收26.55元，成交金额3742万元，换手率0.38%，振幅4.99%，量比0.54。同源康医药-B今日主力资金净流入318万元，上一交易日主力净流出0万元。该股近5个交易日下跌26.07%，主力资金累计净流入1734万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2.02亿元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410171227a6b662f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410171227a6b662f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1515","09939","02410"],"gpt_icon":0},{"id":"2526941304","title":"同源康醫藥(02410)TY-9591入選ASCO 本土創新藥企實現技術突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2526941304","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526941304?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 13:47","pubTimestamp":1744264077,"startTime":"0","endTime":"0","summary":"作为全球肿瘤领域最具权威的学术交流盛会，ASCO 年会将展示当前国际前沿的临床肿瘤学科研成果和肿瘤治疗技术。同源康医药-B核心产品TY-9591的最新研究成果也入选2025年美国临床肿瘤学会大会报告。这是TY-9591首次亮相ASCO大会，并荣获口头报告。随着中国创新药行业的快速发展及突破性成果涌现，将有愈来愈多的本土创新药企凭借自身过硬的技术实力和明星产品走向全球舞台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1276610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","159992","BK1161","06978","02410","159938","BK1574","BK1515","TY"],"gpt_icon":0},{"id":"2526874896","title":"同源康醫藥-B盤中異動 股價大跌5.66%報25.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526874896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526874896?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 09:33","pubTimestamp":1744162415,"startTime":"0","endTime":"0","summary":"2025年04月09日早盘09时33分，同源康医药-B股票出现波动，股价快速跳水5.66%。截至发稿，该股报25.000港元/股，成交量3.75万股，换手率0.01%，振幅9.81%。资金方面，该股资金流入0港元，流出5.115万港元。同源康医药-B股票所在的生物技术行业中，整体跌幅为3.29%。其相关个股中，云康集团、华康生物医学、中生北控生物科技涨幅较大，振幅较大的相关个股有来凯医药-B、科伦博泰生物-B、同源康医药-B，振幅分别为12.45%、11.88%、9.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409093335a4531b22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409093335a4531b22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","02410","BK1161","BK1574"],"gpt_icon":0},{"id":"2525045966","title":"每日賣空追蹤 | 同源康醫藥-B 04月07日賣空量成交1500股，賣空比例為0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525045966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525045966?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 20:13","pubTimestamp":1744027988,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间04月07日，跌18.89%，卖空量成交1500股，较上一交易日减少81.25%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407201314a450e79f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407201314a450e79f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02410","BK1515","09939","BK1161"],"gpt_icon":0},{"id":"2525575036","title":"同源康醫藥-B盤中異動 股價大跌5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525575036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525575036?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 09:30","pubTimestamp":1743989422,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时30分，同源康医药-B股票出现异动，股价急速下挫5.99%。同源康医药-B股票所在的生物技术行业中，整体跌幅为8.07%。其相关个股中，华康生物医学、中生北控生物科技、正大企业国际涨幅较大，振幅较大的相关个股有加科思-B、复宏汉霖、和铂医药-B，振幅分别为9.70%、9.68%、7.95%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093022a6b1ecc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093022a6b1ecc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","09939","BK1515","BK1574"],"gpt_icon":0},{"id":"2524790584","title":"同源康醫藥-B盤中異動 股價大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524790584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524790584?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 10:06","pubTimestamp":1743646003,"startTime":"0","endTime":"0","summary":"2025年04月03日早盘10时06分，同源康医药-B股票出现异动，股价大幅跳水5.27%。资金方面，该股资金流入496.462万港元，流出1077.74万港元。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.70%。其相关个股中，中国抗体-B、帝王国际投资、荣昌生物涨幅较大，振幅较大的相关个股有乐普生物-B、荣昌生物、云康集团，振幅分别为9.76%、8.77%、8.05%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040310064394ca87a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040310064394ca87a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","BK1574","02410","BK1515"],"gpt_icon":0},{"id":"2524499898","title":"每日賣空追蹤 | 同源康醫藥-B 04月02日賣空量成交1.15萬股，賣空比例為0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524499898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524499898?lang=zh_tw&edition=fundamental","pubTime":"2025-04-02 21:12","pubTimestamp":1743599563,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间04月02日，涨5.56%，卖空量成交1.15万股，较上一交易日增加15%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250402211250a44b5689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250402211250a44b5689&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","02410","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2523641340","title":"同源康醫藥公佈2024年業績，關鍵產品商業化潛力進一步釋放","url":"https://stock-news.laohu8.com/highlight/detail?id=2523641340","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523641340?lang=zh_tw&edition=fundamental","pubTime":"2025-03-30 07:30","pubTimestamp":1743291000,"startTime":"0","endTime":"0","summary":"公司于2025年3月9日发布自愿性公告，宣布其自主研发的核心产品TY-9591在治疗 EGFR 突变肺癌脑转移等方面取得了积极进展，计划近期向国家药品监督管理局药品审评中心提交 NDA 上市申请。公司预计将在2025年第四季度实现TY9591的商业化，面对中国非小细胞肺癌及肺癌脑转移治疗中亟待满足的临床需求，TY9591的商业化潜力有望得到快速释放，预计2027年公司将实现收支平衡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4653018_ZH53018_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1161","02410"],"gpt_icon":0},{"id":"1129470875","title":"一週港股牛熊榜 | 醫藥股霸榜！同源康醫藥-B升逾25%，三生製藥升近20%；越疆陷虧損泥沼，跌近15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129470875","media":"老虎資訊","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129470875?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 17:48","pubTimestamp":1743155311,"startTime":"0","endTime":"0","summary":"$三生制药$ 本週升近19%，消息面上，3月25日，三生製藥發佈截至2024年12月31日止年度業績，該集團期內取得收入91.08億元，同比增加16.5%；母公司擁有人應占純利20.90億元，同比增加34.9%；每股基本盈利0.86元；擬派發末期股息每股25港仙。報告顯示，其2024年營收3.74億元，同比增長30.3%；凈利潤虧損9536萬元，同比收窄7.6%；經調整後的淨虧損額爲3650萬元，同比收窄55.4%，毛利率爲46.6%，同比提高了 3.1個百分點。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/6b12b30d7cf0af9a2b6d2683230cd48c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/6b12b30d7cf0af9a2b6d2683230cd48c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02570","01070","09866","02410","00467","01530","02577","02582","02432","02858"],"gpt_icon":1},{"id":"2522547632","title":"同源康醫藥-B03月28日獲主力加倉5365萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522547632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522547632?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 16:16","pubTimestamp":1743149816,"startTime":"0","endTime":"0","summary":"03月28日, 同源康医药-B股价涨1.29%，报收35.45元，成交金额1.55亿元，换手率1.21%，振幅6.86%，量比1.84。同源康医药-B今日主力资金净流入5365万元，连续7日净流入，上一交易日主力净流入2265万元。该股近5个交易日上涨22.97%，主力资金累计净流入9730万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1.24亿元，其中净流入天数为12日。该股主力净额占比0.42%，港股市场排名16/2650。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328165905a6a73506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328165905a6a73506&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","02410","BK1574","BK1161","BK1515"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":132,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2025-04-25","current":-24.758022,"percent":0.42515,"low":-45.171338,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"high":-10.104382,"avg":-24.668389,"sd":6.705729,"marketCap":10197984995},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995}],"updateTime":1745765658800}}}